Phase II trial of DNA methyltransferase 1 inhibition with the antisense oligonucleotide MG98 in patients with metastatic renal carcinoma: A National Cancer Institute of Canada Clinical Trials Group investigational new drug study
Eric Winquist, Jennifer Knox, Jean-Pierre Ayoub, Lori Wood, Nancy Wainman, Gregory K. Reid, Laura Pearce, Ajit Shah, Elizabeth EisenhauerVolume:
24
Language:
english
Pages:
9
DOI:
10.1007/s10637-006-5938-1
Date:
March, 2006
File:
PDF, 786 KB
english, 2006